Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 948046 FRANKFURT AM MAIN, 2M
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$137,014
+$43,167 QoQ
Shares Held
26,098
+3.4% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 98 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $1,001,919,079 across 44 Drug Manufacturers - Specialty & Generic names. LFCR ranks #38 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 5,851,737 $420,505,812
2 VTRS
Viatris Inc
 7,891,271 $125,313,379
3 UTHR
UNITED THERAPEUTICS Corp
 195,269 $105,802,598
4 TEVA
Teva Pharmaceutical Industries Ltd
 3,037,225 $102,901,179
5 NBIX
Neurocrine Biosciences Inc
 334,650 $56,401,907
6 LNTH
Lantheus Holdings, Inc.
 248,743 $27,595,547
7 ANIP
Ani Pharmaceuticals Inc
 323,443 $26,774,610
8 KNSA
Kiniksa Pharmaceuticals International, plc
 387,606 $24,787,402

All Filings in LFCR

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $137,014 26,098
2026-03-31 $93,847 25,228
2025-12-31 $171,346 20,947
2025-09-30 $196,489 26,697
2025-06-30 $3,930 484
2025-03-31 $179,048 25,433
2024-12-31 $188,967 25,433
2024-09-30 $1,556,494 315,719
2024-06-30 $1,619,638 315,719
2024-03-31 $1,676,467 315,719
2023-12-31 $1,954,300 315,719
2023-06-30 $985,817 101,946
2023-03-31 $471,867 124,833
2022-12-31 $771,904 119,121
2022-09-30 $1,001,085 112,608
2022-06-30 $1,140,109 114,354
2022-03-31 $164,436 14,200
2021-12-31 $176,245 15,878
2021-09-30 $138,724 15,046
2021-06-30 $301,027 26,758
2021-03-31 $259,668 24,497
2020-12-31 $370,266 34,126
2020-09-30 $283,978 29,216
2020-06-30 $95,344 11,978
2020-03-31 $71,370 8,213